Versant Venture Management, LLC Long-Term Concentrated

CIK: 0001560009 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 12, 2026

Total Value ($000): $151,061 (100.0% shares, 0.0% debt)

Holdings (7)

Exited Positions (2)

— Repare Therapeutics, Inc. 3.1%

Value ($000) $4,658 Shares 2,646,657 Est. Cost $10.58 Unrealized —

— Adverum Biotechnologies, Inc. 1.5%

Value ($000) $2,296 Shares 506,821 Est. Cost $9646.10 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Repare Therapeutics, Inc.	2,646,657	$4,658	3.1%	$10.58	—	—	760273102
—	Adverum Biotechnologies, Inc.	506,821	$2,296	1.5%	$9646.10	—	—	00773U108

Decreased Positions (1)

GLUE Monte Rosa Therapeutics, Inc. 45.5%

Value ($000) $68,721 (+64.1%) Shares 4,382,687 (-22.5%) Est. Cost $7.50 Unrealized +79.6%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
GLUE	Monte Rosa Therapeutics, Inc.	4,382,687 (-22.5%)	$68,721 (+64.1%)	45.5%	$7.50	+79.6%	Common Stock	61225M102

Unchanged Positions (6)

LENZ Lenz Therapeutics, Inc. 28.1%

Value ($000) $42,510 Shares 2,656,888 Est. Cost $36.77 Unrealized -20.7%

JBIO Jade Biosciences, Inc. 15.6%

Value ($000) $23,543 Shares 1,525,820 Est. Cost $33.31 Unrealized -64.8%

SKYE Skye Bioscience, Inc. 1.0%

Value ($000) $1,505 Shares 2,007,704 Est. Cost $7.75 Unrealized -81.2%

— Tempest Therapeutics, Inc. 0.5%

Value ($000) $774 Shares 269,772 Est. Cost $6.80 Unrealized —

CRSP CRISPR Therapeutics AG 5.2%

Value ($000) $7,805 Shares 148,831 Est. Cost $40.26 Unrealized +48.7%

CTNM Contineum Therapeutics, Inc. 4.1%

Value ($000) $6,202 Shares 542,628 Est. Cost $16.10 Unrealized -29.2%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
LENZ	Lenz Therapeutics, Inc.	2,656,888	$42,510	28.1%	$36.77	-20.7%	Common Stock	52635N103
JBIO	Jade Biosciences, Inc.	1,525,820	$23,543	15.6%	$33.31	-64.8%	Common Stock	008064206
SKYE	Skye Bioscience, Inc.	2,007,704	$1,505	1.0%	$7.75	-81.2%	Common Stock	83086J200
—	Tempest Therapeutics, Inc.	269,772	$774	0.5%	$6.80	—	Common Stock	87978U108
CRSP	CRISPR Therapeutics AG	148,831	$7,805	5.2%	$40.26	+48.7%	Common Shares	H17182108
CTNM	Contineum Therapeutics, Inc.	542,628	$6,202	4.1%	$16.10	-29.2%	Common Stock	21217B100